-
Do you know immunotherapy post-surgery improves overall survival for kidney cancer? Study finds
19 Apr 2024 06:26 GMT
… trial found that an adjuvant therapy improved overall survival in kidney cancer … patients.
According to a review of keynote-564 research findings, treating … , an immunotherapy medication, following surgery … after primary treatment of the cancer …
-
Postsurgical Keytruda Improves Survival in Clear Cell Kidney Cancer
18 Apr 2024 16:44 GMT
… from the KEYNOTE-564 clinical trial. More specifically, researchers from … To be eligible for the trial, patients had to have … cancer. The drug was initially approved in the kidney cancer space in … 2021 for the adjuvant treatment of …
-
Immunotherapy After Kidney Cancer Surgery Improves Overall Survival
18 Apr 2024 09:00 GMT
… in patients with kidney cancer.
Treatment with pembrolizumab, an immunotherapy drug, after surgery significantly … overall survival versus placebo in trial participants. Overall survival benefits with … -cell carcinoma. N Engl J Med. 2024;390(15):1359-1371 …
-
Phase 3 trial shows overall survival benefit from adjuvant therapy in kidney cancer patients
18 Apr 2024 02:04 GMT
… 3 randomized, placebo-controlled trial have shown an overall survival … in patients with kidney cancer.
Treatment with pembrolizumab, an immunotherapy drug, after surgery … overall survival versus placebo in trial participants. Overall survival benefits …
-
Immunotherapy post-surgery improves overall survival for kidney cancer
17 Apr 2024 22:52 GMT
… 3 randomized, placebo-controlled trial have shown an overall survival … in patients with kidney cancer.
Treatment with pembrolizumab, an immunotherapy drug, after surgery …
Randomized controlled/clinical trial
Article Title
Overall Survival with …
-
CDSCO Panel Approves Roche's Protocol Amendment Proposal For Anti-cancer Drug Atezolizumab, Lenvatinib, and Sorafenib Study
14 Apr 2024 16:10 GMT
… ) functional under the Central Drug Standard Control Organisation (CDSCO) … amendment of the Clinical trial titled "A Study …
Lenvatinib is FDA-approved for the treatment of radioactive iodine … is used to treat late-stage kidney cancer (advanced renal cell …
-
VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesis.
18 Apr 2024 10:29 GMT
Clear cell renal cell carcinoma (ccRCC) is characterized by dysregulated hypoxia signaling and a tumor microenvironment (TME) highly enriched in myeloid and lymphoid cells. Loss of the von Hippel Lindau (VHL) gene is a critical early event in ccRCC …
-
Your fairness cream may lead to kidney problems, reveals study
17 Apr 2024 06:37 GMT
… of this condition may even develop kidney cancer.
In the study, there … causes could be infections, drugs, heavy metals, some autoimmune … exposure or due to drugs,” explains nephrologist Dr Topoti … on the cause. “The treatment mainly focuses on blood pressure …
-
Nexavar dosage
16 Apr 2024 20:11 GMT
… Food and Drug Administration (FDA) to treat the … opening medication bottles, ask your pharmacist about … drugs are different. Both of these drugs are approved to treat liver cancer, kidney cancer … treatment to check whether the drug is working to treat …
-
Feds seek at least $125 million damages for Cold War chemical spill at Nebraska missile site
17 Apr 2024 12:34 GMT
… and engaged in discovery. No trial date has been set.
… been linked to liver and kidney cancer and diseases of the immune … for damage caused in the development and deployment of Atlas … is pumped to four treatment plants.
Wastewater treatment plants operated by …